Immune Design Corp. — Form D/A

Immune Design Corp. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2011-10-05. The offering totals $34.0M, of which $23.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Brian AtwoodDirectorSouth San Francisco, CA
David BaltimoreDirectorSan Diego, CA
Bruce CarterDirectorSeattle, WA
Richard KlausnerDirectorSouth San Francisco, CA
Edward PenhoetDirectorSeattle, WA
Steve ReedDirectorSeattle, WA
Alain SchreiberDirectorSAN DIEGO, CA
Steve ReedExecutive OfficerSeattle, WA
Steven ReedDirectorMichigan CIty, IN
Steven ReedExecutive OfficerMichigan CIty, IN
James Paul RickeyExecutive OfficerSeattle, WA
Sammy FarahExecutive OfficerNew York, NY
PETER V SVENNILSONDirectorSAN FRANCISCO, CA
Paul T RickeyExecutive OfficerSeattle, WA
William T RingoDirectorSeattle, WA
Jan Henrik T ter MeulenExecutive OfficerSeattle, WA
Brian V AtwoodDirectorSeattle, WA
Alain V SchreiberDirectorSeattle, WA
Bruce V CarterDirectorSeattle, WA
Wayne R GombotzExecutive OfficerSeattle, WA
James T RickeyExecutive OfficerSeattle, WA
Ed V PenhoetDirectorSeattle, WA
Richard T KenneyExecutive OfficerSeattle, WA
Carlos V PayaDirectorSeattle, WA
Carlos V PayaExecutive OfficerSeattle, WA

Other filings by this issuer (10)

FiledFormOfferingSold
2014-06-12D$18K$18K
2014-06-11D$10$10
2014-06-11D/A$11K$11K
2013-10-31D$57.8M$48.5M
2013-01-30D/A$34.0M$34.0M
2010-08-26D/A$34.0M$12.7M
2010-08-05D$32.0M$12.0M
2009-10-06D$11K$11K
2009-07-29D$14K$14K
2009-07-08D/A$18.0M$14.0M

More